Invention Grant
- Patent Title: Clotting factor-Fc chimeric proteins to treat hemophilia
- Patent Title (中): 凝血因子-Fc嵌合蛋白治疗血友病
-
Application No.: US13792889Application Date: 2013-03-11
-
Publication No.: US08815250B2Publication Date: 2014-08-26
- Inventor: Daniel S. Rivera , Robert T. Peters , Alan J. Bitonti
- Applicant: Biogen Idec Hemophilia Inc.
- Applicant Address: US MA Waltham
- Assignee: Biogen Idec Hemophilia Inc.
- Current Assignee: Biogen Idec Hemophilia Inc.
- Current Assignee Address: US MA Waltham
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K14/745 ; A61K38/36
Abstract:
The invention relates to a chimeric protein comprising at least one clotting factor and at least a portion of an immunoglobulin constant region. The invention relates to a method of treating a hemostatic disorder comprising administering a therapeutically effective amount of a chimeric protein wherein the chimeric protein comprises at least one clotting factor and at least a portion of an immunoglobulin constant region.
Public/Granted literature
- US20130273047A1 Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia Public/Granted day:2013-10-17
Information query
